Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether the PH94B nasal spray is effective for Acute
Treatment of the symptoms of Social Anxiety Disorder (SAD) in adult men and women. The
hypothesis is that PH94B nasal spray (.8 micrograms) has a rapid onset of efficacy to improve
performance and interaction anxiety in patients with diagnosed Social Anxiety Disorder (SAD).